Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Pfizer won't seek coronavirus vaccine authorization until after election
This discussion thread was locked as off-topic by Omaha Steve (a host of the Latest Breaking News forum).
Source: Politico
Pfizer will not seek an emergency authorization for its coronavirus vaccine until after the election, the final blow to President Donald Trump's repeated pledges to make a shot available before Americans cast votes amid the worst pandemic in a century.
Pfizer CEO Albert Bourla said Friday that the company may know whether its vaccine is effective by the end of October, but won't have the safety data the FDA wants at least until the end of November. Amid rising concerns about political pressure on the agency, the FDA released guidance on emergency authorizations that requires vaccine developers to provide two months of safety data on half of the trial participants following the final dose of the vaccine.
"Let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the third week of November," Bourla wrote in an open letter.
Moderna, the other company with a vaccine in a late-stage trial with more than 20,000 enrolled, has also said it won't be ready to file for an emergency authorization before the election. Other vaccines could be ready for FDA review late this year or early 2021, but not by Nov. 3.
Pfizer CEO Albert Bourla said Friday that the company may know whether its vaccine is effective by the end of October, but won't have the safety data the FDA wants at least until the end of November. Amid rising concerns about political pressure on the agency, the FDA released guidance on emergency authorizations that requires vaccine developers to provide two months of safety data on half of the trial participants following the final dose of the vaccine.
"Let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the third week of November," Bourla wrote in an open letter.
Moderna, the other company with a vaccine in a late-stage trial with more than 20,000 enrolled, has also said it won't be ready to file for an emergency authorization before the election. Other vaccines could be ready for FDA review late this year or early 2021, but not by Nov. 3.
Read more: https://www.politico.com/news/2020/10/16/pfizer-coronavirus-vaccine-authorization-election-429797
5 replies
= new reply since forum marked as read
= new reply since forum marked as read
